Intuitive Surgical (ISRG) Stock Forecast & Price Target

$406.78 0.00 (0.00%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$409.89 +3.11 (+0.76%)

As of 04:18 AM Eastern

Compare

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 28 Analyst Ratings

Sell
1

Hold
7

Buy
20

Based on 28 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 1 has given a sell rating, 7 have given a hold rating, 19 have given a buy rating, and 1 has given a strong buy rating for ISRG.

Consensus Price Target

$569.20
39.93% Upside

According to the 28 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $569.20. The highest price target for ISRG is $750.00, while the lowest price target for ISRG is $366.00. The average price target represents a forecasted upside of 39.93% from the current price of $406.78.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISRG Analyst Ratings Over Time

Type	Current Forecast 7/13/25 to 7/13/26	1 Month Ago 6/13/25 to 6/13/26	3 Months Ago 4/14/25 to 4/14/26	1 Year Ago 7/13/24 to 7/13/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	19 Buy rating(s)	19 Buy rating(s)	16 Buy rating(s)	15 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$569.20	$573.42	$604.73	$592.59
Forecasted Upside	39.93% Upside	39.50% Upside	29.43% Upside	15.73% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	Broader Market
Consensus Rating Score	2.71	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	39.93% Upside	701.52% Upside	13.82% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/8/2026	BMO Capital Markets 3 of 5 stars	Vik Chopra Not Rated	Initiated Coverage	Outperform	$518.00	+24.79%
7/8/2026	Citigroup 4 of 5 stars		Reiterated Rating	Buy
7/6/2026	Evercore 3 of 5 stars		Set Target		$430.00	+1.32%
6/12/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$520.00 ➝ $515.00	+26.78%
6/2/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$580.00	+46.04%
6/2/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Sell	$440.00 ➝ $366.00	-8.82%
5/27/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$558.00	+30.63%
5/19/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
4/23/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Overweight	$712.00 ➝ $651.00	+34.61%
4/22/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$653.00 ➝ $604.00	+24.69%
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today
4/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$575.00 ➝ $610.00	+25.19%
4/22/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Hold	$560.00 ➝ $515.00	+7.00%
4/22/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$615.00 ➝ $577.00	+19.88%
4/22/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$622.00 ➝ $573.00	+19.05%
4/22/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Overweight	$625.00 ➝ $550.00	+14.27%
4/22/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$660.00 ➝ $585.00	+21.39%
4/22/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$574.00	+27.19%
4/15/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$650.00 ➝ $580.00	+22.64%
4/13/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Neutral	$575.00 ➝ $525.00	+16.37%
3/30/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
3/17/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andre Salles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$570.00 ➝ $550.00	+13.12%
2/4/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$630.00 ➝ $560.00	+17.03%
1/23/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lee Hambright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$740.00 ➝ $750.00	+42.64%
12/17/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$625.00 ➝ $650.00	+17.21%
12/12/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $654.00	+19.48%
10/24/2025	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$510.00 ➝ $550.00	+0.28%
10/23/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$610.00 ➝ $615.00	+16.69%
7/23/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
1/27/2025	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral	$550.00	-4.17%
1/27/2025	Bernstein Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$655.00 ➝ $700.00	+22.16%
12/5/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$525.00 ➝ $610.00	+11.22%
12/2/2024	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$522.00 ➝ $650.00	+19.93%
10/18/2024	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:14 AM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 10, 2026. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

The current stock price is around $720, reflecting strong market confidence in the company's innovative surgical technologies.
Intuitive Surgical, Inc. is a leader in robotic-assisted surgical systems, particularly with its latest da Vinci surgical systems, which enhance precision and reduce recovery times for patients.
The company has a robust portfolio of reusable and disposable instruments, which provides a steady revenue stream and supports ongoing customer relationships.
Intuitive Surgical, Inc. offers comprehensive training and clinical support, ensuring that healthcare providers can maximize the benefits of their surgical systems, which can lead to increased adoption rates.
Recent advancements in proprietary software enhance the functionality of their surgical systems, positioning the company well in a growing market for minimally invasive procedures.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

Intuitive Surgical, Inc. faces increasing competition from emerging companies in the robotic surgery space, which could impact market share and pricing power.
Regulatory challenges in the medical technology sector can lead to delays in product approvals, potentially hindering growth and innovation.
The high cost of robotic surgical systems may limit adoption among smaller hospitals and surgical centers, affecting overall sales growth.
Market volatility can impact stock performance, and recent fluctuations in the healthcare sector may pose risks to investors.
Dependence on a limited number of key products, such as the da Vinci systems, means that any decline in demand for these products could significantly affect revenue.

ISRG Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $569.20, with a high forecast of $750.00 and a low forecast of $366.00.

28 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There is currently 1 sell rating, 7 hold ratings, 19 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.

According to analysts, Intuitive Surgical's stock has a predicted upside of 39.93% based on their 12-month stock forecasts.

Over the previous 90 days, Intuitive Surgical's stock had 1 upgrade by analysts.

Intuitive Surgical has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, BTIG Research, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Piper Sandler, Raymond James Financial, Robert W. Baird, TD Cowen, The Goldman Sachs Group, Truist Financial, and Weiss Ratings in the past 90 days.

Analysts like Intuitive Surgical more than other "medical" companies. The consensus rating for Intuitive Surgical is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

This page (NASDAQ:ISRG) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ISRG Analyst Ratings Over Time

ISRG Analyst Recommendations By Month

ISRG Price Targets by Month

Intuitive Surgical Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

Intuitive Surgical
Bull Case

Intuitive Surgical
Bear Case

ISRG Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ISRG Analyst Ratings Over Time

ISRG Analyst Recommendations By Month

ISRG Price Targets by Month

Intuitive Surgical Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

Intuitive Surgical Bull Case

Intuitive Surgical Bear Case

ISRG Forecast - Frequently Asked Questions

What is Intuitive Surgical's forecast for 2026?

Should I buy or sell Intuitive Surgical stock right now?

Does Intuitive Surgical's stock price have much upside?

Has Intuitive Surgical been upgraded by Wall Street analysts recently?

What analysts cover Intuitive Surgical?

Do Wall Street analysts like Intuitive Surgical more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Intuitive Surgical Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Intuitive Surgical
Bull Case

Intuitive Surgical
Bear Case